BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12805403)

  • 1. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
    Reijerkerk A; Mosnier LO; Kranenburg O; Bouma BN; Carmeliet P; Drixler T; Meijers JC; Voest EE; Gebbink MF
    Mol Cancer Res; 2003 Jun; 1(8):561-8. PubMed ID: 12805403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
    Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.
    Kranenburg O; Bouma B; Gent YY; Aarsman CJ; Kayed R; Posthuma G; Schiks B; Voest EE; Gebbink MF
    Mol Cell Neurosci; 2005 Mar; 28(3):496-508. PubMed ID: 15737740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z; Hou S
    J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
    Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
    Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostatin signaling and regulation of endothelial cell-matrix interactions.
    Wickström SA; Alitalo K; Keski-Oja J
    Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
    Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
    Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
    Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
    Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
    Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect.
    Huang X; Wong MK; Zhao Q; Zhu Z; Wang KZ; Huang N; Ye C; Gorelik E; Li M
    Cancer Res; 2001 Jan; 61(2):478-81. PubMed ID: 11212235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen.
    Chang JH; Javier JA; Chang GY; Oliveira HB; Azar DT
    FEBS Lett; 2005 Jul; 579(17):3601-6. PubMed ID: 15978592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction.
    Schmidt A; Wenzel D; Thorey I; Sasaki T; Hescheler J; Timpl R; Addicks K; Werner S; Fleischmann BK; Bloch W
    Microvasc Res; 2006 May; 71(3):152-62. PubMed ID: 16650878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of endostatin on embryonic vasculo- and angiogenesis.
    Schmidt A; Wenzel D; Ferring I; Kazemi S; Sasaki T; Hescheler J; Timpl R; Addicks K; Fleischmann BK; Bloch W
    Dev Dyn; 2004 Jul; 230(3):468-80. PubMed ID: 15188432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.